Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
82 studies found for:    hypoparathyroidism
Show Display Options
Rank Status Study
1 Recruiting Survey on Epidemiology of Hypoparathyroidism in France
Condition: Hypoparathyroidism
Intervention: Other: No intervention
2 Completed Hypoparathyroidism in Denmark
Condition: Hypoparathyroidism
Intervention:
3 Recruiting PARADIGHM A Natural History Registry for Patients With Chronic Hypoparathyroidism
Condition: Chronic Hypoparathyroidism
Intervention: Other: None [Natural history registry]
4 Terminated
Has Results
Teriparatide for Postsurgical Hypoparathyroidism
Condition: Hypoparathyroidism Post-surgical
Intervention: Drug: Teriparatide
5 Completed
Has Results
Use of NPSP558 in the Treatment of Hypoparathyroidism
Condition: Hypoparathyroidism
Interventions: Drug: Placebo;   Drug: NPSP558
6 Completed Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy
Condition: Hypoparathyroidism
Intervention: Biological: immediate post operative bioassay of Parathyroid Hormone
7 Completed
Has Results
Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)
Condition: Hypoparathyroidism
Intervention: Drug: NPSP558
8 Completed Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life
Condition: Hypoparathyroidism
Interventions: Drug: a: PTH (1-84);   Drug: b:placebo
9 Recruiting Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy
Condition: Transient Hypoparathyroidism
Interventions: Drug: phosphate and betamethasone acetate, 2 mL.;   Drug: saline 0.9% NaCl
10 Completed
Has Results
Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34
Condition: Hypoparathyroidism
Interventions: Drug: Synthetic Human Parathyroid Hormone 1-34;   Drug: Calcitriol & Calcium
11 Completed
Has Results
A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary
Condition: Hypoparathyroidism
Intervention: Drug: NPSP558
12 Active, not recruiting A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)
Condition: Hypoparathyroidism
Intervention: Drug: NPSP558
13 Completed
Has Results
Bone Properties in Hypoparathyroidism: Effects of PTH
Condition: Hypoparathyroidism
Intervention: Drug: PTH
14 Completed Magnesium Treatment in Hypoparathyroidism
Condition: Hypoparathyroidism
Intervention: Dietary Supplement: magnesium
15 Recruiting Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
Conditions: Chronic Hypoparathyroidism;   Hypoparathyroidism
Intervention: Drug: rhPTH(1-84)
16 Unknown  ADD-ON Study to Existing Hypoparathyroidism Studies
Condition: Hypoparathyroidism
Intervention: Drug: PTH1-84 in parent study
17 Recruiting Corticosteroid Rhythms in Hypoparathyroid Patients
Conditions: Hypoparathyroidism;   Hyperparathyroidism
Intervention: Drug: parathyroid hormon 1-84
18 Completed A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients
Condition: Hypoparathyroidism
Interventions: Dietary Supplement: amorphous calcium carbonate;   Dietary Supplement: crystalline calcium supplements
19 Active, not recruiting Effects of PTH Replacement on Bone in Hypoparathyroidism
Conditions: Hypoparathyroidism;   DiGeorge Syndrome
Intervention: Drug: PTH 1-34
20 Completed A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
Condition: Hypoparathyroidism
Intervention: Drug: EnteraBio's Oral Parathyroid Hormone (1-34)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.